Drug Policy Alliance

Drug Policy Alliance is a U.S.-based nonprofit policy advocacy organization headquartered in New York City, with state offices in California, New York, and Washington, D.C. It works nationally on drug policy reform through policy solutions, organizing, public education, and advocacy focused on evidence, health, equity, and human rights. Its public-facing work centers on ending punitive drug policy and replacing it with regulated, health-oriented approaches.

In psychedelics, DPA is an adjacent drug-policy stakeholder rather than a psychedelic-only organization. It has published documented educational material on psilocybin that frames psychedelics as promising therapeutic tools, discusses harm reduction, and notes the current federal illegality of psilocybin in most cases. Current campaigns also include decriminalization, marijuana criminalization reform, and broader public-health approaches to drug regulation, which makes DPA a relevant collaborator for researchers, clinicians, funders, and patient communities working on access, evidence translation, and equitable policy change.